Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for Exercise in Multiple Sclerosis
NCT03824938Phase 3Completed
- Sponsor
- Columbia University
- Start
- Apr 2019
- Primary completion
- Feb 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in multiple sclerosis (MS), sponsored by Columbia University. Started Apr 2019; status: completed.
02
Drugs
aspirin
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT03824938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03824938.